Skip to content

Clinical trials

Completed Leukemia, Myelomonocytic, Chronic trials in Belgium

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Leukemia, Myelomonocytic, Chronic Status: Completed Country / region: Belgium Clear all

11 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20052
20091
20101
20151
20161
20172

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
European Organisation for Research and Treatment of Cancer - EORTC5
Astex Pharmaceuticals, Inc.1
Millennium Pharmaceuticals, Inc.1
Novartis Pharmaceuticals1
Pfizer1
Takeda1
Traws Pharma, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Leukemia, Myelomonocytic, Chronic11
Myelodysplastic Syndromes8
Leukemia, Myeloid, Acute7
Anemia, Refractory, with Excess of Blasts3
Blast Crisis3
Breast Neoplasms3
Burkitt Lymphoma3
Congenital Abnormalities3
Hodgkin Disease3
Immunoblastic Lymphadenopathy3

Trials

Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.